Related Experiment Video
Updated: Aug 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
A Structure-Aware Multimodal Framework for Drug-Target Interaction Prediction via Heterogeneous Graph Learning
Hua Qian1, Deng Pan2, Liangpeng Nie3
1School of Digital Arts, Suzhou Art and Design Technology Institute, Suzhou, China.
Abstract:
Predicting drug-target interactions is critical for drug discovery, yet many deep learning methods overlook atom-residue-level relationships. We propose Protein Heterogeneous Graph learning for Drug-Target Interaction prediction (PHGDTI), a multimodal framework that integrates sequence and structural cues for binding prediction. Drug and protein sequences are embedded with Mol2Vec and Tasks Assessing Protein Embeddings (TAPE) and refined by a self-attention module. In parallel, a drug-protein graph encoder models three complementary graphs: a drug atom graph, a protein residue graph, and a heterogeneous atom-residue graph. Graph attention layers propagate intra- and intermolecular information, and SAGPooling yields compact structural representations. Fusing these structural and sequence features enables accurate affinity estimation. Experiments on the Davis kinase dataset and GalaxyDB dataset show PHGDTI surpasses competitive baselines, and ablation results highlight the benefit of heterogeneous graph modeling.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets
Quantitative Aspects of Drug-Receptor Interaction
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
